P/N |
Phase |
ID × Length (mm) |
Column Material |
MABIEXKITP-0000 |
Antibodix™ WCX-NP5 |
4.6 × 250 mm |
PEEK |
Proteomix® SCX-NP5 |
4.6 × 250 mm |
PEEK |
Both Antibodix™ WCX and Proteomix® SCX phases are comprised of rigid, spherical, highly cross-linked non-porous poly(styrene divinylbenzene) (PS/DVB) beads. The PS/DVB particle surface is grafted with a highly hydrophilic, neutral polymer layer with a thickness in the range of nanometers. The hydrophobic PS/DVB resin surface is totally covered by a hydrophilic coating which eliminates non-specific bindings with antibody proteins, leading to high efficiency and high recovery separations.
Antibodix™ WCX phase
On top of the hydrophilic layer, weak cation-exchange carboxylate (-COOH) functional groups are attached via a proprietary chemistry, resulting in a high capacity ion-exchange layer.
Proteomix® SCX phase
On top of the hydrophilic layer, strong cation-exchange sulfonate (-SO3H) functional groups are attached via a proprietary chemistry, resulting in a high capacity ion-exchange layer.
bio-equip.cn
Profile
Sepax Technologies, Inc., a privately held company, was founded in Delaware, USA in November 2002. It develops and manufactures HPLC consumables, bulk media, and equipment in liquid chromatography for chemical and biological separations. It is a fast growing technology company and owns patents, proprietary technologies and know-how. Sepax has emerged as a leader in the biological separation industry in the global market.
Business strategies
Sepax Technologies, Inc. develops innovative HPLC consumables, bulk media, and instruments to solve separation challenges in the global market. We provide solution-based products by closely working with our customer scientists in pharmaceuticals, biopharmaceuticals, research institutes and government labs. Our strong technical team develops various methods with our customers to analyze complex biological molecules. As a leader in the biological separation industry, we constantly develop the best bio-separation technologies and products for our global customers. We have reached a competitive position globally in fast growing regions.
Vision Statement
To become a technology leader in the biological separation industry in the global market and provide solution based products and services for our customers.
Operation
Sepax Technologies, Inc.
Our company headquarter in Delaware is located in Delaware Technology Park with facilities of 15,000 ft2 dedicated to the development of separation resin technologies and instrumentation, production of HPLC resins, columns and CE consumables. It is also the marketing and sales center for our US and global markets.
Sales
Domestic
Audrey Fisher
Field Sales Account Manager
(Northern CA areas, UT, CO, OR)
Direct Phone: 925-324-5223
Email: afisher@sepax-tech.com
Kathleen Falls
West Coast Regional Manager
(All other CA areas, WA, TX, AZ, NM, MI)
Direct Phone: 323-228-0004
Email: kfalls@sepax-tech.com
Michael Hunnewell
Field Sales Account Manager
(MA, RI, NH, CT, NY)
Direct Phone: 302-650-3955
Email: mhunnewell@sepax-tech.com
Colleen Callahan
Midwest Account Manager
(WI, IL, IN, OH, MO)
Direct Phone: 302-366-1101, ext 106
Cell Phone: 302-339-8747
Email: ccallahan@sepax-tech.com
All other areas, please contact
Helen Gu
Vice President, Sales
Direct phone: 302-650-3909
Email: hgu@sepax-tech.com
International
Tingting Wu
Executive Account Manager/Marketing
Phone: 302-366-1101, ext 115
Email: twu@sepax-tech.com